It is estimated that 50% of people with glaucoma worldwide remain undiagnosed. Glaucoma is an eye disease that involves the deterioration of the optic nerve, which can cause vision loss and even blindness that is irreversible. Since it is such a slow-progressing disease, many people do not realize they are experiencing symptoms of the disease until a significant amount of their vision is impacted. Due to the detrimental impact of this disease, it is essential for physicians to monitor the onset of glaucoma, especially if the patient is part of one of the groups that are predisposed to the disease, including elderly populations of 60 and over, people with a family history of glaucoma, young adults of African American descent, and people with diabetes. An up-and-coming method to efficiently monitor glaucoma is through telemedicine. Since the COVID-19 pandemic, telemedicine has been further developed and is now used more commonly in the medical field. In the field of ophthalmology, many tests have become available through virtual visits, such as visual acuity tests like basic psychologic, neurologic, external adnexal, pupil, motility, alignment, anterior segment, iris, and corneal light reflex exams. This work focuses on the recent developments and efficiency of telemedicine and why it is essential in monitoring and managing the detrimental disease of glaucoma. Research shows that telemedicine allows patients to successfully get treated for their conditions in a convenient manner before the disease progresses beyond recoverability. Despite the optimism that comes with this newly growing field of technology, further study will be done to resolve the many issues that come with telemedicine and explore the limited amount of treatments available for glaucoma.